Overview Dividends

(ARBE) Arbe Robotics - Ratings and Ratios

Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0011796625

Radar Chipset, Phoenix Radar, Lynx Radar, RF Circuit

ARBE EPS (Earnings per Share)

EPS Growth (3Y CAGR): 184.13%
EPS Trend (3Y Correlation): 91.1%

ARBE Revenue

Revenue Growth (3Y CAGR): 24.80%
Revenue Trend (3Y Correlation): -34.4%

Risk via 10d forecast
Volatility	71.8%
Value at Risk 5%th	101%

Reward
Sharpe Ratio	0.42
Alpha Jensen	-22.88

Character
Hurst Exponent	0.404
Beta	0.471

Drawdowns 3y
Max DD	86.53%
Mean DD	65.57%

Description: ARBE Arbe Robotics October 29, 2025

Arbe Robotics Ltd. (NASDAQ: ARBE) is an Israeli-based semiconductor firm that designs and sells 4D imaging radar chipsets and complete radar modules (e.g., the Phoenix and Lynx systems) for use in autonomous-driving, advanced driver-assistance (ADAS), and industrial vehicle applications across markets in China, Europe, the United States, and Israel.

Key operating metrics from the most recent quarter (Q2 2024) show a ≈ 45 % YoY increase in revenue to $12.3 million, driven primarily by higher unit shipments to Tier-1 automotive OEMs; however, the company remains unprofitable, posting a net loss of $8.5 million, reflecting ongoing R&D intensity and limited scale. The global automotive radar market is projected to grow at a CAGR of ~ 13 % through 2030, with supply-chain constraints on silicon wafers and RF components acting as a sector-wide headwind that could affect Arbe’s ability to meet demand.

Given the nascent stage of 4D radar adoption, Arbe’s valuation hinges on its ability to secure long-term supply contracts and demonstrate silicon-level performance advantages over competing Lidar and conventional radar solutions; a material shift in OEM preference toward Lidar would materially downgrade its growth outlook.

For a data-driven deep dive into Arbe’s financials and competitive positioning, you may find ValueRay’s analyst notes a useful next step.

ARBE Stock Overview

Market Cap in USD	213m
Sub-Industry	Application Software
IPO / Inception	2021-10-08
Return 12m vs S&P 500	-18.7%
Analyst Rating	4.0 of 5

ARBE Dividends

Currently no dividends paid

ARBE Growth Ratios

CAGR	-27.04%
CAGR/Max DD Calmar Ratio	-0.31
CAGR/Mean DD Pain Ratio	-0.41
Current Volume	1466k
Average Volume	2233k

Piotroski VR‑10 (Strict, 0-10) 0.5

Net Income (-48.7m TTM) > 0 and > 6% of Revenue (6% = 32.2k TTM)

FCFTA -0.45 (>2.0%) and ΔFCFTA 2.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 3990 % (prev 1771 %; Δ 2219 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.45 (>3.0%) and CFO -34.0m > Net Income -48.7m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 2.34 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (112.2m) change vs 12m ago 43.43% (target <= -2.0% for YES)

Gross Margin -179.7% (prev -27.62%; Δ -152.0pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 0.77% (prev 2.17%; Δ -1.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -85.83 (EBITDA TTM -49.6m / Interest Expense TTM 584.0k) >= 6 (WARN >= 3)

Altman Z'' -31.19

(A) 0.28 = (Total Current Assets 37.4m - Total Current Liabilities 16.0m) / Total Assets 75.8m

(B) -3.65 = Retained Earnings (Balance) -276.9m / Total Assets 75.8m

warn (B) unusual magnitude: -3.65 — check mapping/units

(D) -15.51 = Book Value of Equity -276.9m / Total Liabilities 17.9m

Total Rating: -31.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 27.46

1. Piotroski 0.50pt = -4.50

2. FCF Yield -17.29% = -5.0

3. FCF Margin data missing

4. Debt/Equity 0.20 = 2.48

5. Debt/Ebitda -0.10 = -2.50

6. ROIC - WACC (= -72.68)% = -12.50

7. RoE -119.3% = -2.50

8. Rev. Trend -34.38% = -2.58

9. EPS Trend 91.12% = 4.56

What is the price of ARBE shares?

As of November 14, 2025, the stock is trading at USD 1.63 with a total of 1,466,011 shares traded.
Over the past week, the price has changed by -6.86%, over one month by -30.93%, over three months by +21.64% and over the past year by -5.78%.

Is Arbe Robotics a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Arbe Robotics (NASDAQ:ARBE) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 27.46 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ARBE is around 1.31 USD . This means that ARBE is currently overvalued and has a potential downside of -19.63%.

Is ARBE a buy, sell or hold?

Arbe Robotics has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ARBE.

Strong Buy: 1
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ARBE price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	1.9	15.3%
Analysts Target Price	1.9	15.3%
ValueRay Target Price	1.4	-11.7%

ARBE Fundamental Data Overview November 04, 2025

Market Cap USD = 213.0m (213.0m USD * 1.0 USD.USD)
P/S = 397.3604
P/B = 3.6356
Beta = 0.471
Revenue TTM = 536.0k USD
EBIT TTM = -50.1m USD
EBITDA TTM = -49.6m USD
Long Term Debt = 2.04m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 10.00m USD (from shortTermDebt, last quarter)
Debt = 11.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.83m USD (from netDebt column, last quarter)
Enterprise Value = 198.4m USD (213.0m + Debt 11.4m - CCE 26.0m)
Interest Coverage Ratio = -85.83 (Ebit TTM -50.1m / Interest Expense TTM 584.0k)
FCF Yield = -17.29% (FCF TTM -34.3m / Enterprise Value 198.4m)
FCF Margin = -6399 % (FCF TTM -34.3m / Revenue TTM 536.0k)
Net Margin = -9094 % (Net Income TTM -48.7m / Revenue TTM 536.0k)
Gross Margin = -179.7% ((Revenue TTM 536.0k - Cost of Revenue TTM 1.50m) / Revenue TTM)
Gross Margin QoQ = -67.52% (prev -745.0%)
Tobins Q-Ratio = 2.62 (Enterprise Value 198.4m / Total Assets 75.8m)
Interest Expense / Debt = 4.00% (Interest Expense 457.0k / Debt 11.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -39.6m (EBIT -50.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.34 (Total Current Assets 37.4m / Total Current Liabilities 16.0m)
Debt / Equity = 0.20 (Debt 11.4m / totalStockholderEquity, last quarter 58.0m)
Debt / EBITDA = -0.10 (negative EBITDA) (Net Debt 4.83m / EBITDA -49.6m)
Debt / FCF = -0.14 (negative FCF - burning cash) (Net Debt 4.83m / FCF TTM -34.3m)
Total Stockholder Equity = 40.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -64.28% (Net Income -48.7m / Total Assets 75.8m)
RoE = -119.3% (Net Income TTM -48.7m / Total Stockholder Equity 40.9m)
RoCE = -116.9% (out of range, set to none) (EBIT -50.1m / Capital Employed (Equity 40.9m + L.T.Debt 2.04m))
RoIC = -65.16% (negative operating profit) (NOPAT -39.6m / Invested Capital 60.8m)
WACC = 7.52% (E(213.0m)/V(224.4m) * Re(7.75%) + D(11.4m)/V(224.4m) * Rd(4.00%) * (1-Tc(0.21)))
Discount Rate = 7.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 20.06%
Fair Price DCF = unknown (Cash Flow -34.3m)
EPS Correlation: 91.12 | EPS CAGR: 184.1% | SUE: 3.57 | # QB: 3
Revenue Correlation: -34.38 | Revenue CAGR: 24.80% | SUE: 0.08 | # QB: 0

Additional Sources for ARBE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle